Related references
Note: Only part of the references are listed.Δ9-Tetrahydrocannabinol suppresses vomiting behavior and Fos expression in both acute and delayed phases of cisplatin-induced emesis in the least shrew
Andrew P. Ray et al.
BEHAVIOURAL BRAIN RESEARCH (2009)
The Endocannabinoid System: A Promising Target for the Management of Type 2 Diabetes
Andre J. Scheen
CURRENT PROTEIN & PEPTIDE SCIENCE (2009)
Rimonabant Ameliorates Insulin Resistance via both Adiponectin-dependent and Adiponectin-independent Pathways
Taku Watanabe et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Characterization of a Cannabinoid CB2 Receptor-Selective Agonist, A-836339 [2,2,3,3-Tetramethyl-cyclopropanecarboxylic Acid [3-(2-Methoxy-ethyl)-4,5-dimethyl-3H-thiazol-(2Z)-ylidene]-amide], Using in Vitro Pharmacological Assays, in Vivo Pain Models, and Pharmacological Magnetic Resonance Imaging
Betty B. Yao et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2009)
Sustained antinociceptive effect of cannabinoid receptor agonist WIN 55,212-2 over time in rat model of neuropathic spinal cord injury pain
Aldric Hama et al.
JOURNAL OF REHABILITATION RESEARCH AND DEVELOPMENT (2009)
Analgesic and antiinflammatory effects of cannabinoid receptor agonists in a rat model of neuropathic pain
Anna Leichsenring et al.
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY (2009)
Antinociceptive effects of the non-selective cannabinoid receptor agonist CP 55,940 are absent in CB1(-/-) and not CB2(-/-) mice in models of acute and persistent pain
Nova M. H. Sain et al.
NEUROPHARMACOLOGY (2009)
Smoked Medicinal Cannabis for Neuropathic Pain in HIV: A Randomized, Crossover Clinical Trial
Ronald J. Ellis et al.
NEUROPSYCHOPHARMACOLOGY (2009)
A CB2 RECEPTOR AGONIST, A-836339, MODULATES WIDE DYNAMIC RANGE NEURONAL ACTIVITY IN NEUROPATHIC RATS: CONTRIBUTIONS OF SPINAL AND PERIPHERAL CB2 RECEPTORS
S. McGaraughty et al.
NEUROSCIENCE (2009)
Neuropathic pain behaviours in a chronic-relapsing model of experimental autoimmune encephalomyelitis (EAE)
Camille J. Olechowski et al.
PAIN (2009)
Spinal microglial and perivascular cell cannabinoid receptor type 2 activation reduces behavioral hypersensitivity without tolerance after peripheral nerve injury
Alfonso Romero-Sandoval et al.
ANESTHESIOLOGY (2008)
Sulfamoyl benzamides as novel CB2 cannabinoid receptor ligands
Karin Worm et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2008)
Cannabinoid CB2 receptors: a therapeutic target for the treatment of inflammatory and neuropathic pain
J. Guindon et al.
BRITISH JOURNAL OF PHARMACOLOGY (2008)
Modulation of the anti-nociceptive effects of 2-arachidonoyl glycerol by peripherally administered FAAH and MGL inhibitors in a neuropathic pain model
J. Desroches et al.
BRITISH JOURNAL OF PHARMACOLOGY (2008)
In vitro and in vivo characterization of A-796260: a selective cannabinoid CB2 receptor agonist exhibiting analgesic activity in rodent pain models
B. B. Yao et al.
BRITISH JOURNAL OF PHARMACOLOGY (2008)
MDA7: a novel selective agonist for CB2 receptors that prevents allodynia in rat neuropathic pain models
M. Naguib et al.
BRITISH JOURNAL OF PHARMACOLOGY (2008)
Adverse effects of medical cannabinoids: a systematic review
Tongtong Wang et al.
CANADIAN MEDICAL ASSOCIATION JOURNAL (2008)
Evidence for a novel functional role of cannabinoid CB2 receptors in the thalamus of neuropathic rats
M. D. Jhaveri et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2008)
Study of the regulation of the endocannabinoid system in a virus model of multiple sclerosis reveals a therapeutic effect of palmitoylethanolamide
Frida Loria et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2008)
Involvement of central cannabinoid CB2 receptor in reducing mechanical allodynia in a mouse model of neuropathic pain
Wataru Yamamoto et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2008)
Decreased basal endogenous opioid levels in diabetic rodents: Effects on morphine and delta-9-tetrahydrocannabinoid-induced antinociception
Jovan Williams et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2008)
Design and synthesis of a novel series of N-alkyl isatin acylhydrazone derivatives that act as selective cannabinoid receptor 2 agonists for the treatment of neuropathic pain
Philippe Diaz et al.
JOURNAL OF MEDICINAL CHEMISTRY (2008)
Crucial Role of CB2 Cannabinoid Receptor in the Regulation of Central Immune Responses during Neuropathic Pain
Ildiko Racz et al.
JOURNAL OF NEUROSCIENCE (2008)
Interferon-γ Is a Critical Modulator of CB2 Cannabinoid Receptor Signaling during Neuropathic Pain
Ildiko Racz et al.
JOURNAL OF NEUROSCIENCE (2008)
Efficacy of dronabinol as an adjuvant treatment for chronic pain patients on opioid therapy
Sanjeet Narang et al.
JOURNAL OF PAIN (2008)
A randomized, placebo-controlled, crossover trial of cannabis cigarettes in neuropathic pain
Barth Wilsey et al.
JOURNAL OF PAIN (2008)
Selective Activation of Cannabinoid CB2 Receptors Suppresses Neuropathic Nociception Induced by Treatment with the Chemotherapeutic Agent Paclitaxel in Rats
Elizabeth J. Rahn et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2008)
AM404, an anandamide transport inhibitor, reduces plasma extravasation in a model of neuropathic pain in rat: Role for cannabinoid receptors
G. La Rana et al.
NEUROPHARMACOLOGY (2008)
Actions of N-arachidonyl-glycine in a rat neuropathic pain model
Leeza A. Q. Wong et al.
NEUROPHARMACOLOGY (2008)
Antihyperalgesic effect of a Cannabis sativa extract in a rat model of neuropathic pain:: Mechanisms involved
Francesca Comelli et al.
PHYTOTHERAPY RESEARCH (2008)
Analysis of nociception, sex and peripheral nerve innervation in the TMEV animal model of multiple sclerosis
Jessica L. Lynch et al.
PAIN (2008)
A prospective identification of neuropathic pain in specific chronic polyneuropathy syndromes and response to pharmacological therapy
Cory Toth et al.
PAIN (2008)
Cannabinoid receptor CB2 localisation and agonist-mediated inhibition of capsaicin responses in human sensory neurons
Uma Anand et al.
PAIN (2008)
The putative cannabinoid receptor GPR55 plays a role in mechanical hyperalgesia associated with inflammatory and neuropathic pain
Penny C. Staton et al.
PAIN (2008)
Effect of cannabinoid receptor agonists on streptozotocin-induced hyperalgesia in diabetic neuropathy
Magdalena Bujalska
PHARMACOLOGY (2008)
Comparison of analgesic effects and patient tolerability of nabilone and dihydrocodeine for chronic neuropathic pain: randomised, crossover, double blind study
B. Frank et al.
BRITISH MEDICAL JOURNAL (2008)
The effect of the palmitoylethanolamide analogue, palmitoylallylamide (L-29) on pain behaviour in rodent models of neuropathy
V. C. J. Wallace et al.
BRITISH JOURNAL OF PHARMACOLOGY (2007)
Activation of cannabinoid CB1 and CB2 receptors suppresses neuropathic nociception evoked by the chemotherapeutic agent vincristine in rats
E. J. Rahn et al.
BRITISH JOURNAL OF PHARMACOLOGY (2007)
Pharmacological, behavioural and mechanistic analysis of HIV-1 gp120 induced painful neuropathy
Victoria C. J. Wallace et al.
PAIN (2007)
Sativex successfully treats neuropathic pain characterised by allodynia: A randomised, double-blind, placebo-controlled clinical trial
Turo J. Nurmikko et al.
PAIN (2007)
The local antinociceptive effects of paracetamol in neuropathic pain are mediated by cannabinoid receptors
Melina Dania et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2007)
Expression of cannabinoid CB1 receptors in models of diabetic neuropathy
Fan Zhang et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2007)
Characterization of rodent models of HIV-gp120 and anti-retroviral-associated neuropathic pain
Victoria C. J. Wallace et al.
BRAIN (2007)
Reassessment of the role of cannabinoids in the management of pain
Pierre Beaulieu et al.
CURRENT OPINION IN ANESTHESIOLOGY (2007)
Oromucosal Δ9-tetrahydrocannabinol/cannabidiol for neuropathic pain associated with multiple sclerosis:: An uncontrolled, open-label, 2-year extension trial
David J. Rog et al.
CLINICAL THERAPEUTICS (2007)
Central glucocorticoid receptors regulate the upregulation of spinal cannabinoid-1 receptors after peripheral nerve injury in rats
Shuxing Wang et al.
PAIN (2007)
Insulin differentially modulates the peripheral endocannabinoid system in human subcutaneous abdominal adipose tissue from lean and obese individuals
G. Murdolo et al.
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION (2007)
The treatment of spasticity with Δ9-tetrahydrocannabinol in persons with spinal cord injury
U. Hagenbach et al.
SPINAL CORD (2007)
The synthetic cannabinoid HU-210 attenuates neural damage in diabetic mice and hyperglycemic pheochromocytoma PC12 cells
Yossi Dagon et al.
NEUROBIOLOGY OF DISEASE (2007)
Pre-emptive antinociceptive effects of a synthetic cannabinoid in a model of neuropathic pain
Jose Guindon et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2007)
WIN 55,212-2 prevents mechanical allodynia but not alterations in feeding behaviour induced by chronic cisplatin in the rat
Gerna Vera et al.
LIFE SCIENCES (2007)
The fatty acid amide hydrolase inhibitor URB597 (cyclohexylcarbamic acid 3′-carbamoylbiphenyl-3-yl ester) reduces neuropathic pain after oral administration in mice
Roberto Russo et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2007)
The synthetic cannabinoids attenuate allodynia and hyperalgesia in a rat model of trigeminal neuropathic pain
Ying-Ching Liang et al.
NEUROPHARMACOLOGY (2007)
Cannabinoids mediate analgesia largely via peripheral type 1 cannabinoid receptors in nociceptors
Nitin Agarwal et al.
NATURE NEUROSCIENCE (2007)
Novel inhibitors of fatty acid amide hydrolase
S. Y. Sit et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2007)
Antinociceptive effect of cannabinoid agonist WIN 55,212-2 in rats with a spinal cord injury
Aldric Hama et al.
EXPERIMENTAL NEUROLOGY (2007)
Further characterization of a rat model of varicella zoster virus-associated pain: Relationship between mechanical hypersensitivity and anxiety-related behavior, and the influence of analgesic drugs
F. S. Hasnie et al.
NEUROSCIENCE (2007)
Cannabis in painful HIV-associated sensory neuropathy - A randomized placebo-controlled trial
D. I. Abrams et al.
NEUROLOGY (2007)
The non-psychoactive cannabis constituent cannabidiol is an orally effective therapeutic agent in rat chronic inflammatory and neuropathic pain
Barbara Costa et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2007)
Changes in spinal and supraspinal endocannabinoid levels in neuropathic rats
Stefania Petrosino et al.
NEUROPHARMACOLOGY (2007)
Meta-analysis of cannabis based treatments for neuropathic and multiple sclerosis-related pain
Michael Iskedjian et al.
CURRENT MEDICAL RESEARCH AND OPINION (2007)
Palmitoylethanolamide, endocannabinoids and related cannabimimetic compounds in protection against tissue inflammation and pain: Potential use in companion animals
G. Re et al.
VETERINARY JOURNAL (2007)
Cannabidiol - Recent advances
Raphael Mechoulam et al.
CHEMISTRY & BIODIVERSITY (2007)
Inhibition of fatty acid amide hydrolase produces analgesia by multiple mechanisms
Leon Chang et al.
BRITISH JOURNAL OF PHARMACOLOGY (2006)
AM404, an inhibitor of anandamide uptake, prevents pain behaviour and modulates cytokine and apoptotic pathways in a rat model of neuropathic pain
Barbara Costa et al.
BRITISH JOURNAL OF PHARMACOLOGY (2006)
Analgesic effects of fatty acid amide hydrolase inhibition in a rat model of neuropathic pain
Maulik D. Jhaveri et al.
JOURNAL OF NEUROSCIENCE (2006)
Site-specific increases in peripheral cannabinoid receptors and their endogenous ligands in a model of neuropathic pain
Somsak Mitrirattanakul et al.
PAIN (2006)
Changes in endocannabinoid and palmitoylethanolamide levels in eye tissues of patients with diabetic retinopathy and age-related macular degeneration
I. Matias et al.
PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS (2006)
Rapid broad-spectrum analgesia through activation of peroxisome proliferator-activated receptor-α
Jesse LoVerme et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2006)
Effects of a cannabinoid agonist on spinal nociceptive neurons in a rodent model of neuropathic pain
Cheng Liu et al.
JOURNAL OF NEUROPHYSIOLOGY (2006)
Low dose treatment with the synthetic cannabinoid Nabilone significantly reduces spasticity-related pain -: A double-blind placebo-controlled cross-over trial
Joerg Wissel et al.
JOURNAL OF NEUROLOGY (2006)
Neuropathic pain and the endocannabinoid system in the dorsal raphe: pharmacological treatment and interactions with the serotonergic system
Enza Palazzo et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2006)
Modulation of neuropathic and inflammatory pain by the endocannabinoid transport inhibitor AM404 [N-(4-hydroxyphenyl)-eicosa-5,8,11,14-tetraenamide]
G. La Rana et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2006)
Benefits of an add-on treatment with the synthetic cannabinomimetic nabilone on patients with chronic pain -: a randomized controlled trial
Martin Pinsger et al.
WIENER KLINISCHE WOCHENSCHRIFT (2006)
Antihyperalgesic effects of local injections of anandamide, ibuprofen, rofecoxib and their combinations in a model of neuropathic pain
Josee Guindon et al.
NEUROPHARMACOLOGY (2006)
Characterization of chronic constriction of the saphenous nerve, a model of neuropathic pain in mice showing rapid molecular and electrophysiological changes
Jean-Sebastien Walczak et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2006)
Pharmacological characterisation of place escape/avoidance behaviour in the rat chronic constriction injury model of neuropathic pain
LH Pedersen et al.
PSYCHOPHARMACOLOGY (2006)
Expression of the cannabinoid CB2 receptor in the rat cerebellum: An immunohistochemical study
JC Ashton et al.
NEUROSCIENCE LETTERS (2006)
COX-2, CB2 and P2X7-immunoreactivities are increased in activated microglial cells/macrophages of multiple sclerosis and amyotrophic lateral sclerosis spinal cord
Y Yiangou et al.
BMC NEUROLOGY (2006)
CB2 receptor-mediated antihyperalgesia: possible direct involvement of neural mechanisms
M Beltramo et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2006)
Cannabinoid CB2 receptors: Immunohistochemical localization in rat brain
JP Gong et al.
BRAIN RESEARCH (2006)
Different effects of opioid and cannabinoid receptor agonists on C-fiber-induced extracellular signal-regulated kinase activation in dorsal horn neurons in normal and spinal nerve-ligated rats
Y Kawasaki et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2006)
Actions of the FAAH inhibitor URB597 in neuropathic and inflammatory chronic pain models
A Jayamanne et al.
BRITISH JOURNAL OF PHARMACOLOGY (2006)
Experience with the synthetic cannabinoid nabilone in chronic noncancer pain
DM Berlach et al.
PAIN MEDICINE (2006)
A role for cannabinoid receptors, but not endogenous opioids, in the antinociceptive activity of the CB2-selective agonist, GW405833
GT Whiteside et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2005)
Cannabinoids in multiple sclerosis (CAMS) study: safety and efficacy data for 12 months follow up
JP Zajicek et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2005)
A cannabinoid agonist, WIN 55,212-2, reduces neuropathic nociception induced by paclitaxel in rats
D Pascual et al.
PAIN (2005)
Identification and functional characterization of brainstem cannabinoid CB2 receptors
MD Van Sickle et al.
SCIENCE (2005)
Activation of the peripheral endocannabinoid system in human obesity
S Engeli et al.
DIABETES (2005)
Randomized, controlled trial of cannabis-based medicine in central pain in multiple sclerosis
DJ Rog et al.
NEUROLOGY (2005)
Effect of the cannabinoid ajulemic acid on rat models of neuropathic and inflammatory pain
VA Mitchell et al.
NEUROSCIENCE LETTERS (2005)
Anandamide induced PPARγ transcriptional activation and 3T3-L1 preadipocyte differentiation
M Bouaboula et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2005)
Antihyperalgesic properties of the cannabinoid CT-3 in chronic neuropathic and inflammatory pain states in the rat
A Dyson et al.
PAIN (2005)
Effect of the cannabinoid CB1 receptor antagonist, SR141716, on nociceptive response and nerve demyelination in rodents with chronic constriction injury of the sciatic nerve
B Costa et al.
PAIN (2005)
An endocannabinoid mechanism for stress-induced analgesia
AG Hohmann et al.
NATURE (2005)
Pharmacological evaluation of the selective spinal nerve ligation model of neuropathic pain in the rat
CJ LaBuda et al.
JOURNAL OF NEUROSCIENCE METHODS (2005)
Pain measurements and side effect profile of the novel cannabinoid ajulemic acid
K Salim et al.
NEUROPHARMACOLOGY (2005)
The CNS role of Toll-like receptor 4 in innate neuroimmunity and painful neuropathy
FY Tanga et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Cannabis use in HIV for pain and other medical symptoms
E Woolridge et al.
JOURNAL OF PAIN AND SYMPTOM MANAGEMENT (2005)
Pharmacological and pharmacokinetic characterization of the cannabinoid receptor 2 agonist, GW405833, utilizing rodent models of acute and chronic pain, anxiety, ataxia and catalepsy
KJ Valenzano et al.
NEUROPHARMACOLOGY (2005)
AM404, an inhibitor of anandamide reuptake decreases Fos-immunoreactivity in the spinal cord of neuropathic rats after non-noxious stimulation
LF Rodella et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2005)
The nuclear receptor peroxisome proliferator-activated receptor-alpha mediates the anti-inflammatory actions of palmitoylethanolamide
J Lo Verme et al.
MOLECULAR PHARMACOLOGY (2005)
Peripheral nerve injury induces cannabinoid receptor 2 protein expression in rat sensory neurons
G Wotherspoon et al.
NEUROSCIENCE (2005)
Behavioral, pharmacological and molecular characterization of the saphenous nerve partial ligation: A new model of neuropathic pain
JS Walczak et al.
NEUROSCIENCE (2005)
Ethosuximide reverses paclitaxel- and vincristine-induced painful peripheral neuropathy
SJL Flatters et al.
PAIN (2004)
Are oral cannabinoids safe and effective in refractory neuropathic pain?
N Attal et al.
EUROPEAN JOURNAL OF PAIN (2004)
Antihyperalgesic effect of the cannabinoid agonist WIN55,212-2 is mediated through an interaction with spinal metabotropic glutamate-5 receptors in rats
AT Hama et al.
NEUROSCIENCE LETTERS (2004)
Cannabinoid-induced presynaptic inhibition at the primary afferent trigeminal synapse of juvenile rat brainstem slices
YC Liang et al.
JOURNAL OF PHYSIOLOGY-LONDON (2004)
Cannabinoids blocks tactile allodynia in diabetic mice without attenuation of its antinociceptive effect
A Dogrul et al.
NEUROSCIENCE LETTERS (2004)
3-[2-cyano-3-(trifluoromethyl)phenoxy]phenyl-4,4,4-trifluoro-1-butanesulfonate (BAY 59-3074):: A novel cannabinoid CB1/CB2 receptor partial agonist with antihyperalgesic and antiallodynic effects
J De Vry et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2004)
Does the cannabinoid dronabinol reduce central pain in multiple sclerosis? Randomised double blind placebo controlled crossover trial
KB Svendsen et al.
BMJ-BRITISH MEDICAL JOURNAL (2004)
Efficacy of two cannabis based medicinal extracts for relief of central neuropathic pain from brachial plexus avulsion: results of a randomised controlled trial
JS Berman et al.
PAIN (2004)
The effect of WIN 55,212-2, a cannabinoid agonist, on tactile allodynia in diabetic rats
A Ulugol et al.
NEUROSCIENCE LETTERS (2004)
Repeated treatment with the synthetic cannabinoid WIN 55,212-2 reduces both hyperalgesia and production of pronociceptive mediators in a rat model of neuropathic pain
B Costa et al.
BRITISH JOURNAL OF PHARMACOLOGY (2004)
Mice lacking fatty acid amide hydrolase exhibit a cannabinoid receptor-mediated phenotypic hypoalgesia
AH Lichtman et al.
PAIN (2004)
Cannabinoid CB2 receptor activation inhibits mechanically evoked responses of wide dynamic range dorsal horn neurons in naive rats and in rat models of inflammatory and neuropathic pain
SJR Elmes et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2004)
Pharmacological characterization of the chronic constriction injury model of neuropathic pain
J De Vry et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2004)
Evidence that CB-1 and CB-2 cannabinoid receptors mediate antinociception in neuropathic pain in the rat
DA Scott et al.
PAIN (2004)
Initial experiences with medicinal extracts of cannabis for chronic pain: Results from 34 'N of 1' studies
W Notcutt et al.
ANAESTHESIA (2004)
Cannabinoids for treatment of spasticity and other symptoms related to multiple sclerosis (CAMS study): multicentre randomised placebo-controlled trial
J Zajicek et al.
LANCET (2003)
Analgesic effect of the synthetic cannabinoid CT-3 on chronic neuropathic pain - A randomized controlled trial
M Karst et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2003)
Inhibitory effect of anandamide on resiniferatoxin-induced sensory neuropeptide release in vivo and neuropathic hyperalgesia in the rat
Z Helyes et al.
LIFE SCIENCES (2003)
Activation of CB2 cannabinoid receptors by AM1241 inhibits experimental neuropathic pain:: Pain inhibition by receptors not present in the CNS
MM Ibrahim et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Upregulation of spinal cannabinoid-1-receptors following nerve injury enhances the effects of Win 55,212-2 on neuropathic pain behaviors in rats
G Lim et al.
PAIN (2003)
Short-term effects of cannabinoids in patients with HIV-1 infection - A randomized, placebo-controlled clinical trial
DI Abrams et al.
ANNALS OF INTERNAL MEDICINE (2003)
Induction of CB2 receptor expression in the rat spinal cord of neuropathic but not inflammatory chronic pain models
J Zhang et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2003)
Pharmacological sensitivity and gene expression analysis of the tibial nerve injury model of neuropathic pain
HA Hofmann et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2003)
Changes in sensory processing in the spinal dorsal horn accompany vincristine-induced hyperalgesia and allodynia
HR Weng et al.
PAIN (2003)
Activation and binding of peroxisome proliferator-activated receptor γ by synthetic cannabinoid ajulemic acid
JL Liu et al.
MOLECULAR PHARMACOLOGY (2003)
A preliminary controlled study to determine whether whole-plant cannabis extracts can improve intractable neurogenic symptoms
DT Wade et al.
CLINICAL REHABILITATION (2003)
Chronic pain after clip-compression injury of the rat spinal cord
JC Bruce et al.
EXPERIMENTAL NEUROLOGY (2002)
Brain monoglyceride lipase participating in endocannabinoid inactivation
TP Dinh et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
An endogenous capsaicin-like substance with high potency at recombinant and native vanilloid VR1 receptors
SM Huang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Characterization of a novel endocannabinoid, virodhamine, with antagonist activity at the CB1 receptor
AC Porter et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2002)
Fatty acid amide hydrolase, an enzyme with many bioactive substrates. Possible therapeutic implications
T Bisogno et al.
CURRENT PHARMACEUTICAL DESIGN (2002)
A painful peripheral neuropathy in the rat produced by the chemotherapeutic drug, paclitaxel
RC Polomano et al.
PAIN (2001)
Functional changes in the inhibitory effect of spinal cannabinoid (CB) receptor activation in nerve injured rats
V Chapman
NEUROPHARMACOLOGY (2001)
CB2 cannabinoid receptor-mediated peripheral antinociception
TP Malan et al.
PAIN (2001)
Supersensitivity to anandamide and enhanced endogenous cannabinoid signaling in mice lacking fatty acid amide hydrolase
BF Cravatt et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Cannabinoids for control of chemotherapy induced nausea and vomiting:: quantitative systematic review
MR Tramèr et al.
BMJ-BRITISH MEDICAL JOURNAL (2001)
The synthetic cannabinoid WIN55,212-2 attenuates hyperalgesia and allodynia in a rat model of neuropathic pain
D Bridges et al.
BRITISH JOURNAL OF PHARMACOLOGY (2001)
The role of central and peripheral Cannabinoid1 receptors in the antihyperalgesic activity of cannabinoids in a model of neuropathic pain
A Fox et al.
PAIN (2001)
2-Arachidonyl glyceryl ether, an endogenous agonist of the cannabinoid CB1 receptor
L Hanus et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Cannabinoid CB1 receptor upregulation in a rat model of chronic neuropathic pain
A Siegling et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2001)
Structure-activity relationship for the endogenous cannabinoid, anandamide, and certain of its analogues at vanilloid receptors in transfected cells and vas deferens
RA Ross et al.
BRITISH JOURNAL OF PHARMACOLOGY (2001)
Actions of cannabinoid receptor ligands on rat cultured sensory neurones: implications for antinociception
RA Ross et al.
NEUROPHARMACOLOGY (2001)
Spared nerve injury: an animal model of persistent peripheral neuropathic pain
I Decosterd et al.
PAIN (2000)
Immunomodulation by cannabinoids is absent in mice deficient for the cannabinoid CB2 receptor
NE Buckley et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2000)
Share Paper
